Barinthus Biotherapeutics
1.03
0.06 (6.19%)
At close: Jan 15, 2025, 12:05 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -1.93 16.39 -8.12 -0.04 n/a
PS Ratio 176.62 1.96 1.54K 0.14 n/a
PB Ratio 0.76 0.36 1.64 -0.02 n/a
P/FCF Ratio -2.51 -4.26 -12.25 -0.06 n/a
P/OCF Ratio -2.78 -6.07 -12.68 -0.06 n/a
OCF/S Ratio -63.5 -0.32 -121.58 -2.29 -2.73
Debt / Equity Ratio 0.07 0.04 0.03 -1.24 -0.08
Quick Ratio 12.45 17.40 20.32 6.27 2.83
Current Ratio 12.45 17.40 20.32 6.27 2.83
Asset Turnover 0.00 0.17 0.00 0.10 0.36
Interest Coverage -3.00K -212.68 -16.95 -5.57 -193.33
Return on Equity (ROE) -0.39 0.02 -0.2 0.47 0.93
Return on Assets (ROA) -0.34 0.02 -0.18 -0.35 -1.09
Return on Capital (ROIC) -0.42 -0.02 -0.17 -0.47 -1.94
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 100.00% 100.00% 100.00% 100.00%
Net Profit Margin -9.15K% 11.95% -18.98K% -367.27% -302.84%
Pretax Profit Margin -9.54K% 1.90% -19.08K% -370.01% -331.6%
Operating Profit Margin -10.46K% -9.04% -16.87K% -415.81% -374.94%
FCF Margin -7.02K% -46.01% -12.59K% -234.83% -274.8%
EBITDA Margin -8.86K% 14.33% -17.86K% -293.29% -324.61%